In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nobel Biocare Holding AG

Division of Danaher Corp.
www.nobelbiocare.com

Latest From Nobel Biocare Holding AG

Danaher Buys Filtration Firm Pall, Will Split Into Two

The major acquisition will be followed by a company split – the Danaher name will stay with the business that includes diagnostics and dental segments, and a second, more industrial-focused company will be formed by the end of 2016.

Medtech 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models

Healthy market growth, the biggest ever M&A deal, a record number of billion-dollar takeovers, and the IPO market in impressive bounce-back…2014 was a year of superlatives for the global medtech industry. But with more expected of manufacturers while health care spending remains in the doldrums and demand for care rises, the long-term medtech winners will be those who can forecast how and where to make an impact on both costs and patient outcomes.

Medical Device Deals

Medtech In 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models

Medtech manufacturers saw 2014 as the year of the medtech mega-merger and a rebound in IPOs. But the market is changing, and companies are increasingly cast as service providers who must deliver value.

Medical Device Deals

Device/Diagnostics Quarterly Deal Statistics, Q3 2014

Device financing decreased to $734 million in Q3, less than half the Q2 total, and the $4.9 billion in M&As was a sharp decline versus Q2. Diagnostics fundraising, at $399 million, showed a 31% drop from Q2, and Merck KGAA’s $16.7 billion buy of Sigma-Aldrich made up 96% of the Q3 M&A activity.

Medical Device Deals
See All

Company Information

  • Industry
  • Medical Devices
    • Biomaterials
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
    • Implantable Devices
  • Services
    • Diagnostic Imaging Services
  • Therapeutic Areas
  • Dental & Oral Products
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Company Type
  • Midsize European
  • Parent & Subsidiaries
  • Danaher Corp.
  • Senior Management
  • Richard T Laube, CEO
    Oliver Walker, EVP & CFO
    Rolf Watter, COB
    Dietmar Bettio, EVP & CIO
  • Contact Info
  • Nobel Biocare Holding AG
    Phone: 43 211 42 00
    Balz Zimmermann-Strasse 7
    Balsberg
    Kloten, CH-8302
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register